Covid-19 Long Haulers

Pensum Regenerative Medicine
09 February 2021
https://www.pensummed.pro/blogs/covid-19-long-haulers

Low-Dose Naltrexone for Fibromyalgia and ME/CFS

Verywell Health
04 November 2020
https://www.verywellhealth.com/low-dose-naltrexone-ldn-for-fibromyalgia-cfs-716070

Low-Dose Naltrexone for Treating MS Symptoms

Verywell Health
05 January 2020
https://www.verywellhealth.com/naltrexone-for-ms-2440888

NutriChem's LDN Book Event with Dr. Yousuf Siddiqui (Low dose naltrexone) from LDN Research Trust on Vimeo.

Dr. Yousuf Siddiqui, B.Arch.Sci., N.D

Autoimmunity, The Thyroid, Low-dose Naltrexone (LDN) & Beyond

Naltrexone Restores Impaired Transient Receptor Potential Melastatin 3 Ion Channel Function in Natural Killer Cells From Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients

Front. Immunol
31 October 2019
https://www.frontiersin.org/articles/10.3389/fimmu.2019.02545/full

Low-dose naltrexone in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Fatigue: Biomedicine, Health & Behavior
19 November 2019
https://www.tandfonline.com/doi/abs/10.1080/21641846.2019.1692770?journalCode=rftg20

Low-dose Naltrexone as a Treatment for Chronic Fatigue Syndrome

BMJ Case Reports
06 January 2020
https://casereports.bmj.com/content/13/1/e232502

Low-Dose Naltrexone: An Inexpensive Medicine for Many Ills?

Medscape Medical News
11 Mar 2020
https://www.medscape.com/viewarticle/926611?src=WNL_trdalrt_201027_MSCPEDIT&uac=267476HJ&impID=2640101&f

 

Dr Kent Holtorf delivers his presentation on Thyroid Conditions at the LDN 2014 Conference.

In this presentation Dr Holtorf speaks about the mechanisms which Hashimoto’s and Grave’s disease operate under and how, after many years of research and practice, they can be countered through unconventional treatments.